A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

New sleeping pill on the market





Belsomra Information from

8/15/2014
01:27 | Author: Christina Harris

New sleeping pill on the market
Belsomra Information from

The U.S. Food and Drug Administration (FDA) has approved the Belsomra, an orexin receptor antagonist, is the first approved drug in this new class. of orexin, a chemical involved in the sleep-wake cycle in the brain.

Pregnancy Category C Risk cannot be ruled out.

This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products.

The film coating contains: lactose monohydrate, hypromellose, titanium dioxide, and triacetin. Inactive ingredients: Polyvinylpyrrolidone/vinyl acetate copolymer (copovidone), microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, and magnesium stearate.

Comments (1)Read more



FDA OKs New Kind of Sleep Drug Suvorexant (Belsomra) - Medscape

6/14/2014
03:14 | Author: Devin Garcia

New sleeping pill on the market
FDA OKs New Kind of Sleep Drug Suvorexant (Belsomra) - Medscape

The US Food and Drug Administration (FDA) today approved a first-in-class insomnia drug called suvorexant (Belsomra, Merck) after the.

Medscape: Medscape Access In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.

Medscape uses cookies to customize the site based on the information we collect at registration. The cookies contain no personally identifiable information and have no effect once you leave the Medscape site.

Comments (0)

FDA OKs New Sleeping Drug from Merck Fox Business

4/13/2014
05:21 | Author: Christina Harris

New sleeping pill on the market
FDA OKs New Sleeping Drug from Merck Fox Business

Merck & Co. has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep.

View Article Advertisement. You must login to comment.

Apple’s fourth-quarter earnings easily topped Wall Street estimates, helped in part by the release of new iPhone devices at the tail end of the period. Industries Industries Markets Industries.

Morning Biz Outlook › Advertisement Reuters.

MPP director of federal policies Daniel Riffle on the latest on marijuana legalization.

You're logged in as REUTERS.

2014 FOX News Network, LLC. This material may not be published, broadcast, rewritten, or redistributed.

( MRK ) has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep. WASHINGTON – Merck & Co.

It's unclear whether the new drug is safer or more effective than older drugs because it was tested against a dummy pill, rather than other sleeping medications. The tablet, Belsomra, works by temporarily blocking chemicals known as orexins that control the sleep cycle and can keep people awake at night.

Dow Jones & Company Terms & Conditions. Powered and Implemented by Interactive Data Managed Solutions. Mutual fund and ETF data provided by Lipper. Earnings estimates data provided by Zacks. Real-time quotes provided by BATS Exchange. Market Data provided by Interactive Data ( Terms & Conditions ). Company fundamental data provided by Morningstar. Quotes delayed at least 15 minutes. Economic data provided by Econoday.

The agency notes that patients who took the highest dose, 20 milligrams, experienced drowsiness and difficulty driving the following morning. The Food and Drug Administration approved the drug in four different doses for various degrees of insomnia. The FDA says doctors should warn patients taking that dose against next-day driving or activities that require full concentration.

Comments (0)

Suvorexant FDA Says New Sleeping Pill Seems Effective, But

2/12/2014
07:48 | Author: Caitlin White

New sleeping pill on the market
Suvorexant FDA Says New Sleeping Pill Seems Effective, But

the drug. Merck's shares fell 1.1 percent to $45.49 in midday trading. Suvorexant is the first in a new class of sleep medications that block.

Get top stories and blog posts ed to me each day.

* Reviewers say lower doses of suvorexant safer than high * Cite risk of next-day sedation, suicidal thinking * Merck shares fall 1 percent in midday trading.

But if you’re one to hit the treadmill while watching Jimmy Kimmel, rethink your routine. One of the roughly million benefits of regular exercise is that it can deepen your sleep. Vigorous exercise within two hours of bedtime can make it tough to fall asleep.

Choose a bedtime that's about eight hours before you want to wake up, and stick to it each night.

Comments (4)Read more

Coming Soon A New Sleep Drug - WSJ

10/21/2014
01:05 | Author: Kate Thompson

New sleeping pill on the market
Coming Soon A New Sleep Drug - WSJ

A new sleep drug by Merck & Co. is expected to gain U.S. approval in the coming months, even as its main competitor is coming under growing.

is expected to gain U.S. A new sleep drug by Merck & Co. approval in the coming months, even as its main competitor is coming under growing scrutiny by regulators and doctors for sometimes-dangerous side effects.

By using our website or by closing this message box, you agree to our use of cookies as described in our Cookie Policy. We use cookies to help us deliver our online services.

Comments (0)